Latest Half Year Results News

Cycliq Group’s Q3 FY2026 customer receipts fell 23% year-on-year to $561k, though a late March UpRide Birthday campaign injected $256k in revenue. Operating cash outflows reflect prior quarter cost settlements, with hopes for cost normalisation and sales momentum in Q4.

Singular Health has received a US$500,000 payment from Provider Network Solutions following the deployment of an additional 500 3DICOM MD® licenses, marking progress in commercial adoption and cost-saving benefits within a major US healthcare network.

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Nuix has completed its acquisition of Paris-based Linkurious, integrating advanced graph data visualisation technology and boosting its full year Annualised Contract Value guidance to $252 million–$272 million.

Navigator Global Investments (ASX: NGI) reported a 9% jump in ownership-adjusted assets under management to USD31.6 billion for Q3 FY26, driven by strong inflows, strategic acquisitions, and solid hedge fund performance amid market volatility.

Naos Small Cap Opportunities Company has kicked off an on-market buy-back program set to repurchase up to 10% of its issued shares over the next year, signalling a notable capital management move.

Charter Hall Social Infrastructure REIT (ASX: CQE) has announced a 4.30 cents per unit interim distribution for Q1 2026, accompanied by an 8.5762 cents per unit fund payment under the AMIT regime. The payment date is set for 21 April 2026, with detailed withholding tax components primarily affecting non-resident investors.

ECP Emerging Growth Limited’s portfolio plunged 19.4% in the March quarter, dragging its net tangible asset value down by nearly 30%, as growth stocks stumbled amid geopolitical tensions and rising rates. The fund added furniture retailer Koala Company and sees value in its resilient holdings despite the rough patch.

Botanix Pharmaceuticals has agreed to terms with Piramal to establish an alternate supplier for the active ingredient in Sofdra, aiming to reduce costs by up to 40% and strengthen its supply chain.

DGL Group reported a 5.8% revenue decline to $225.2 million in H1 FY26, weighed down by audit qualifications, ERP rollout delays, and one-off impairments. Despite these headwinds, the company cut net debt by $16.4 million and advanced strategic site consolidations and new facility investments.

Fletcher Building posted a mixed quarterly volume update for Q3 FY26, with gains in light building products and distribution offset by weakness in heavy materials. The recent Middle East conflict adds new supply chain and cost pressures, complicating the outlook.

XRF Scientific posted a 13.8% jump in March quarter revenue to $15.8 million, led by strong international sales and new product shipments. The newly operational India office marks a strategic expansion, setting the stage for further growth.